FBLG FibroBiologics, Inc. Common Stock
Healthcare$1.06+0.95%ClosedMarket Cap: $2.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.90
P/S
0.00
EV/EBITDA
-0.17
DCF Value
$1.11
FCF Yield
-713.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-767.1%
ROA
-314.6%
ROIC
-355.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-5.1M | $-5.0M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.6M | $-3.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-16.6M | $-18.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.0M | $-5.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.5M | $-4.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.5M | $-5.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.7M | $-3.1M | $— | — |
| FY null | $0.00 | NaN% | $-13.7M | $-11.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.4M | $-500.0K | $— | — |
| Q2 null | $0.00 | NaN% | $-3.2M | $898.0K | $— | — |
| Q1 null | $0.00 | NaN% | $-3.5M | $-8.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-2.5M | $-9.7M | $-6.20 | — |